The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, is a National Cancer Institute-designated Comprehensive Cancer Center located on Northwestern Memorial Hospital's downtown medical campus in the Streeterville neighborhood of Chicago, Illinois, United States.

During the past decade, Robert H. Lurie Comprehensive Cancer Center at Northwestern University conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 93 clinical trials were completed, i.e. on average, 182.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 39 clinical trials were completed. i.e. 195% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" #1 sponsor was "Northwestern University" with 91 trials, followed by "Eastern Cooperative Oncology Group" with 69 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored and "National Cancer Institute (NCI)" with 19 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 102 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" #1 collaborator was "National Cancer Institute (NCI)" with 260 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "Eastern Cooperative Oncology Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 13 trials as a collaborator and "NRG Oncology" with 12 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" are "Breast Cancer" (50 trials), "Lymphoma" (47 trials), "Leukemia" (34 trials), "Colorectal Cancer" (28 trials) and "Lung Cancer" (23 trials). Many other conditions were trialed in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" in a lesser frequency.

Most popular intervention types in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" are "Drug" (298 trials), "Biological" (95 trials), "Procedure" (84 trials), "Radiation" (73 trials) and "Other" (29 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (45 trials), "cyclophosphamide" (39 trials), "paclitaxel" (32 trials), "filgrastim" (29 trials) and "fluorouracil" (28 trials). Other intervention names were less common.

The vast majority of trials in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University" are 314 trials for "All" genders, 53 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Robert H. Lurie Comprehensive Cancer Center at Northwestern University". undefined are not yet recruiting, 14 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 270 completed trials in Robert H. Lurie Comprehensive Cancer Center at Northwestern University, undefined suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in Robert H. Lurie Comprehensive Cancer Center at Northwestern University, 70 "Phase 1" clinical trials were conducted, 219 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".